A recent study published in The New England Journal of Medicine and an FDA committee hearing suggest that a stool test called Cologuard will likely be approved as a non-invasive screening for colorectal cancer.
A recent study published in The New England Journal of Medicine and an FDA committee hearing suggest that a stool test called Cologuard will likely be approved as a non-invasive screening for colorectal cancer.
Share this Article
Comment on this Article
Recommended
Please to comment